2023 FOM 1

Change in anything is often met with trepidation but change often brings opportunities. During this session we will review the fundamentals of value based care and how it compares to the current reimbursement environment for FQHC’s. We will also discuss the financial implications of value-based care and share how proposed changes can be a win-win for both patients and your financial statements. A discussion will occur on staffing priorities for value-based care along with financial opportunities and some pitfalls to avoid during the transition..

Health centers need to have positive bottom lines to fund growth and development. This session will show the link between budgeting and profitability and identify key drivers of the health center’s bottom line.

Learn about health center industry benchmarks and how to use them in your practice to better manage cost, productivity and revenue by establishing goals and objectives for budgeting and realization of better financial performance.

There are unique aspects to how health centers must bill and receive payment for the services they provide.
Explanations of how reimbursement for Medicare PPS, Medicaid, sliding fee scales, and other revenue streams operate are discussed. This session will also cover Medicare cost reporting including discussion on patient visits, reclassifications and adjustments, and the draft of the new Medicare Cost Report form.

In addition to step by step instruction on how to fill out and file the Federal Financial Report (FFR Form 425), this session also provides an outline that includes an understanding of its purpose and guidance on the information collected on the FFR form.

In addition to step by step instruction on how to fill out and file the Federal Financial Report (FFR Form 425), this session also provides an outline that includes an understanding of its purpose and guidance on the information collected on the FFR form.

The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.

This session will address the current trends of health care and the issues that the CHC of 2025 may face. Will risk-based contracts be the norm? Will collaboration with hospitals or other health care providers be financially significant to the bottom line? What will compliance look like in 2025? Understanding that some variables are unknown, what financial and operational decisions should be considered to strengthen financial metrics, improve operating performance, and reduce risk? What resources, both financial and human, will be needed to meet the challenges of the future? Special consideration will be given to best practices in the strategic planning process to help CHCs financially prepare for providing primary and preventative health care in the future.